Screener
HealthEquity HQY Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by HealthEquity in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: HealthEquity’s 10-Q, filed May 28, 2026.
- Filed
- May 28, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001428336-26-000028
| (in thousands) | Three months ended April 30, 2026 | Three months ended April 30, 2025 |
|---|---|---|
| Net income | $69,418 | $53,915 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 38,214 | 38,741 |
| Stock-based compensation | 19,406 | 14,336 |
| Amortization of debt discount and issuance costs | 277 | 265 |
| Amortization of gains on derivatives | (196) | — |
| Deferred taxes | 10,106 | 1,324 |
| Changes in operating assets and liabilities: |
Item 1. Financial statements
FAQ
- What is HealthEquity's stock-based comp?
- HealthEquity (HQY) reported stock-based comp of $19.41M in Q1 2026.
- How has HealthEquity's stock-based comp changed year-over-year?
- HealthEquity's stock-based comp increased by 35.4% year-over-year, from $14.34M to $19.41M.
- What is the long-term trend for HealthEquity's stock-based comp?
- Over 4 years (2022 to 2026), HealthEquity's stock-based comp has grown at a 8.5% compound annual growth rate (CAGR), from $52.75M to $73.06M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about HealthEquity's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude